JP2003528139A - 炎症性サイトカインおよびケモカインの発現を阻害する方法 - Google Patents
炎症性サイトカインおよびケモカインの発現を阻害する方法Info
- Publication number
- JP2003528139A JP2003528139A JP2001570257A JP2001570257A JP2003528139A JP 2003528139 A JP2003528139 A JP 2003528139A JP 2001570257 A JP2001570257 A JP 2001570257A JP 2001570257 A JP2001570257 A JP 2001570257A JP 2003528139 A JP2003528139 A JP 2003528139A
- Authority
- JP
- Japan
- Prior art keywords
- astaxanthin
- expression
- chemokines
- xanthophyll
- inflammatory cytokines
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/05—Chlorophycota or chlorophyta (green algae), e.g. Chlorella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Rheumatology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- Alternative & Traditional Medicine (AREA)
- Toxicology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0001071-0 | 2000-03-27 | ||
| SE0001071A SE0001071D0 (sv) | 2000-03-27 | 2000-03-27 | Method of inhibiting the expression of inflammatory cytokines and chemokines |
| PCT/SE2001/000600 WO2001072296A1 (en) | 2000-03-27 | 2001-03-21 | Method of inhibiting the expression of inflammatory cytokines and chemokines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003528139A true JP2003528139A (ja) | 2003-09-24 |
| JP2003528139A5 JP2003528139A5 (cg-RX-API-DMAC7.html) | 2008-05-15 |
Family
ID=20279020
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001570257A Pending JP2003528139A (ja) | 2000-03-27 | 2001-03-21 | 炎症性サイトカインおよびケモカインの発現を阻害する方法 |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1267857B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2003528139A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE353639T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2001242965A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2405479C (cg-RX-API-DMAC7.html) |
| DE (1) | DE60126591D1 (cg-RX-API-DMAC7.html) |
| SE (1) | SE0001071D0 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2001072296A1 (cg-RX-API-DMAC7.html) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005074907A1 (ja) * | 2004-02-04 | 2005-08-18 | Fuji Chemical Industry Co., Ltd. | 遺伝子発現調節剤 |
| JP2006008719A (ja) * | 2005-06-23 | 2006-01-12 | Yamaha Motor Co Ltd | 血中過酸化脂質抑制剤 |
| JP2006008714A (ja) * | 2005-03-17 | 2006-01-12 | Yamaha Motor Co Ltd | マトリックスメタロプロテイナーゼ阻害剤 |
| JP2006008718A (ja) * | 2005-06-03 | 2006-01-12 | Yamaha Motor Co Ltd | シクロオキシゲナーゼ活性阻害剤 |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003048202A2 (en) * | 2001-12-03 | 2003-06-12 | Asahi Kasei Pharma Corporation | Nf-kappab activating genes |
| US7805004B2 (en) * | 2007-02-28 | 2010-09-28 | Microsoft Corporation | Radical set determination for HMM based east asian character recognition |
| WO2008106606A2 (en) * | 2007-02-28 | 2008-09-04 | Cardax Pharmaceuticals, Inc. | Carotenoid analogs and derivatives in the treatment of prostate cancer |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05155736A (ja) * | 1991-12-10 | 1993-06-22 | Nakano Seiyaku Kk | 化粧料 |
| JPH09143063A (ja) * | 1995-11-22 | 1997-06-03 | Kose Corp | 外用に適する組成物 |
| WO1998037874A1 (en) * | 1997-02-27 | 1998-09-03 | Astacarotene Ab | Oral preparation for the prophylactic and therapeutic treatment of helicobacter sp. infection |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0799924A (ja) * | 1993-09-30 | 1995-04-18 | Nippon Suisan Kaisha Ltd | アスタキサンチンを主要成分とするファフィア色素油の安定な粉末化物及びその製造方法 |
| JPH07300421A (ja) * | 1994-04-28 | 1995-11-14 | Itano Reitou Kk | 抗炎症剤 |
| US5527533A (en) * | 1994-10-27 | 1996-06-18 | Board Of Trustees Of The University Of Illinois | Method of retarding and ameliorating central nervous system and eye damage |
| US5886053A (en) * | 1995-02-03 | 1999-03-23 | Basf Aktiengesellschaft | Use of carotenoids for producing drugs for the treatment of dermatoses |
| JPH09124470A (ja) * | 1995-10-26 | 1997-05-13 | Suntory Ltd | 抗ストレス組成物 |
| EP0984915A4 (en) * | 1997-04-04 | 2002-11-27 | Henkel Corp | LUTEINE ESTERS WITH HIGH BIOAVAILABILITY |
| SE512531C2 (sv) * | 1997-09-04 | 2000-03-27 | Astacarotene Ab | Användning av åtminstone en typ av xantofyller för framställning av ett läkemedel för profylaktisk och/eller terapeutisk förbättring av muskelfunktionsdurationen hos däggdjur och/eller behandling av muskelstörningar eller - sjukdomar hos däggdjur |
-
2000
- 2000-03-27 SE SE0001071A patent/SE0001071D0/xx unknown
-
2001
- 2001-03-21 AU AU2001242965A patent/AU2001242965A1/en not_active Abandoned
- 2001-03-21 AT AT01916022T patent/ATE353639T1/de not_active IP Right Cessation
- 2001-03-21 CA CA2405479A patent/CA2405479C/en not_active Expired - Fee Related
- 2001-03-21 DE DE60126591T patent/DE60126591D1/de not_active Expired - Fee Related
- 2001-03-21 EP EP01916022A patent/EP1267857B1/en not_active Expired - Lifetime
- 2001-03-21 JP JP2001570257A patent/JP2003528139A/ja active Pending
- 2001-03-21 WO PCT/SE2001/000600 patent/WO2001072296A1/en not_active Ceased
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05155736A (ja) * | 1991-12-10 | 1993-06-22 | Nakano Seiyaku Kk | 化粧料 |
| JPH09143063A (ja) * | 1995-11-22 | 1997-06-03 | Kose Corp | 外用に適する組成物 |
| WO1998037874A1 (en) * | 1997-02-27 | 1998-09-03 | Astacarotene Ab | Oral preparation for the prophylactic and therapeutic treatment of helicobacter sp. infection |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005074907A1 (ja) * | 2004-02-04 | 2005-08-18 | Fuji Chemical Industry Co., Ltd. | 遺伝子発現調節剤 |
| JPWO2005074907A1 (ja) * | 2004-02-04 | 2007-09-13 | 富士化学工業株式会社 | 遺伝子発現調節剤 |
| US10828269B2 (en) | 2004-02-04 | 2020-11-10 | Fuji Chemical Industries Co., Ltd. | Reducing muscle atrophy by administering astaxanthin |
| JP2006008714A (ja) * | 2005-03-17 | 2006-01-12 | Yamaha Motor Co Ltd | マトリックスメタロプロテイナーゼ阻害剤 |
| JP2006008718A (ja) * | 2005-06-03 | 2006-01-12 | Yamaha Motor Co Ltd | シクロオキシゲナーゼ活性阻害剤 |
| JP2006008719A (ja) * | 2005-06-23 | 2006-01-12 | Yamaha Motor Co Ltd | 血中過酸化脂質抑制剤 |
Also Published As
| Publication number | Publication date |
|---|---|
| SE0001071D0 (sv) | 2000-03-27 |
| DE60126591D1 (de) | 2007-03-29 |
| ATE353639T1 (de) | 2007-03-15 |
| CA2405479C (en) | 2010-11-16 |
| AU2001242965A1 (en) | 2001-10-08 |
| CA2405479A1 (en) | 2001-10-04 |
| EP1267857A1 (en) | 2003-01-02 |
| WO2001072296A1 (en) | 2001-10-04 |
| EP1267857B1 (en) | 2007-02-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zhang et al. | Inhibition of HDAC6 attenuates LPS-induced inflammation in macrophages by regulating oxidative stress and suppressing the TLR4-MAPK/NF-κB pathways | |
| Zhong et al. | Energy stress modulation of AMPK/FoxO3 signaling inhibits mitochondria-associated ferroptosis | |
| Xu et al. | 5-(3, 4-Difluorophenyl)-3-(6-methylpyridin-3-yl)-1, 2, 4-oxadiazole (DDO-7263), a novel Nrf2 activator targeting brain tissue, protects against MPTP-induced subacute Parkinson's disease in mice by inhibiting the NLRP3 inflammasome and protects PC12 cells against oxidative stress | |
| EP3641819B1 (en) | Use of cannabidiol in the treatment of tuberous sclerosis complex | |
| Saihara et al. | Pyrroloquinoline quinone, a redox-active o-quinone, stimulates mitochondrial biogenesis by activating the SIRT1/PGC-1α signaling pathway | |
| Lee et al. | SIRT1 protein, by blocking the activities of transcription factors FoxO1 and FoxO3, inhibits muscle atrophy and promotes muscle growth | |
| CA2292497C (en) | Dietary compositions for enhancing metabolism and alleviating oxidative stress | |
| CN1947717B (zh) | 选择性抑制腺苷酸环化酶1的化合物在制备用于治疗神经性疼痛和炎性疼痛的药物中的应用 | |
| HU229263B1 (en) | The use of pharmaceutical compositions containing 4-h-1-benzopyran-4-one derivatives as inhibitors of smooth muscle cell proliferation | |
| Igawa et al. | N‐(4‐hydroxyphenyl) retinamide induces cell cycle specific growth inhibition in PC3 cells | |
| KR20130128018A (ko) | 새로운 노화 방지 물질 및 그 확인 방법 | |
| Liu et al. | Cytochrome P450 enzymes mediated by DNA methylation is involved in deoxynivalenol-induced hepatoxicity in piglets | |
| US20070088078A1 (en) | Methods for managing adipocyte fat accumulation | |
| Xu et al. | Ferulic acid suppresses activation of hepatic stellate cells through ERK1/2 and Smad signaling pathways in vitro | |
| Li et al. | Corylifol A suppresses osteoclastogenesis and alleviates ovariectomy-induced bone loss via attenuating ROS production and impairing mitochondrial function | |
| Zhu et al. | Vinpocetine inhibits RANKL-induced osteoclastogenesis and attenuates ovariectomy-induced bone loss | |
| Zhu et al. | HDAC6 alleviates prion peptide-mediated neuronal death via modulating PI3K-Akt-mTOR pathway | |
| IL268345B (en) | Preparations and methods for promoting hair growth with mpc1 inhibitors | |
| US7078040B2 (en) | Method of inhibiting the expression of inflammatory cytokines and chemokines | |
| CN104873500A (zh) | 化合物zln005的用途 | |
| Li et al. | PGC-1α Promotes mitochondrial biosynthesis and energy metabolism of goose fatty liver | |
| Walker | Reactive oxygen species in status epilepticus | |
| CN120860041A (zh) | 王百合苷b的应用 | |
| EP1501520A1 (en) | Pharmaceutical compositions for lowering blood glucose and blood cholesterol levels | |
| CA2405479C (en) | Method of inhibiting the expression of inflammatory cytokines and chemokines |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20060220 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20060220 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080321 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20080321 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110624 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110823 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20111007 |